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1. Abstract 1 
Expressed breast milk (EBM) is commonly supplemented with commercially prepared human milk 2 
fortifier to meet the additional nutritional needs of preterm infants. The optimal milk intake at which to 3 
introduce fortification is unknown. The objective of this systematic review was to compare the effect of 4 
early fortification (EF) versus that of delayed introduction of human milk fortifier (DF) on short-term 5 
outcomes including growth, feeding intolerance, length of hospital stay and maturity at discharge in 6 
very low birth weight infants. The search was carried out until March 2019 using five electronic 7 
databases (PubMed, Ovid Medline, web of science, Ovid Embase and the Cochrane Library). The search 8 
was supplemented with a search of the clinical trial registry and reference lists. Eligible studies involved 9 
randomized controlled trials that had been designed to compare EF against DF using multi-nutrient 10 
fortifier for infants of birth weight <1500 g who were fed exclusively or predominantly EBM. Four 11 
authors independently screened the studies for eligibility. A total of 1972 articles were screened; two 12 
studies met the inclusion criteria and were included with a total number of participants of 171. The 13 
definition of EF and DF was not consistent between the two studies. There was no significant impact of 14 
EF versus DF on all outcomes. In conclusion, current data are limited and do not provide evidence on the 15 
optimal time to start fortification. The definition of EF and DF needs to be agreed and further larger 16 
randomized controlled trials are required.  17 
18 
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2. Introduction 19 
The third trimester of pregnancy is a period of nutrient accretion and growth. Preterm infants have 20 
missed some or all of that period, and therefore their nutritional requirement is much higher than that 21 
of term infants. Preterm infants accumulate significant nutrient deficiency in early postnatal life which 22 
may result in growth restriction (weight below the 10th centile for postmenstrual age). Poor growth is a 23 
very common problem in the preterm infant population, with poor postnatal growth found in 99% of 24 
extremely low birth weight infants (1) and can be associated with a higher risk for short term 25 
morbidities (2-4). Postnatal growth restriction has been associated with poorer neurodevelopmental 26 
outcomes and may continue to affect ex-preterm infants during later childhood and adulthood (5-7). 27 
Expressed breast milk (EBM) confers numerous advantages for preterm infants, especially those born 28 
with a very low birth weight (VLBW) (8). However, when fed as the only source of nutrition, EBM does 29 
not meet the preterm infant’s increased nutritional requirements (9, 10). The protein requirement of 30 
growing preterm infants is between 3.5 and 4.5 g/kg/day (11). Feeding with 150 ml/kg/day of unfortified 31 
EBM (often considered full enteral feeding) provides only about 1.8 g/kg/day of protein. Providing 32 
optimal early nutrition to preterm infants is challenging, but it can be facilitated by the use of multi-33 
nutrient human milk fortifier (HMF). The addition of a HMF to EBM is recommended but there is no 34 
consensus on the timing at which HMF can safely be introduced and practice vary greatly. Fortification 35 
alters both the nutrient density and osmolality of EBM, which may affect intestinal peristalsis and feed 36 
tolerance, and increase the risk of necrotizing enterocolitis (NEC) (12). Historically, this has been used as 37 
a justification for delaying the introduction of HMF. There is some evidence that these adverse 38 
outcomes may be more common with the use of bovine-based HMF, but the data are limited (13-15). 39 
However, any risk needs to be balanced against the early introduction of HMF to avoid postnatal growth 40 
failure, which itself may have adverse neurodevelopmental consequences. The aim of this systematic 41 
review was to compare in-hospital outcomes of early versus delayed introduction of multi-nutrient 42 
human milk fortifier. Outcomes of interest were short-term growth, feeding intolerance, length of 43 
hospital stay and post-menstrual age (PMA) at discharge.  44 
3. Methods 45 
Search  46 
Published literature was searched up to 28th of March 2019, using five databases. The reference lists of 47 
the most relevant papers and reviews were searched manually. The clinical trial registration websites 48 
(clinicaltrial.gov) and Current Controlled Trials (isrctn.com) were searched for ongoing or completed 49 
trials. Abstracts were considered for inclusion only if they contained the necessary information. The 50 
search strategy was based on MeSH terms/subject headings and separate keywords. The MeSH terms 51 
were the following: fortified food, human milk, premature infant, growth & development, mortality, low 52 
birth weight, breast milk and diet supplementation. The keywords were human milk, breast milk and 53 
fortification. Boolean terms (AND, OR) were used to connect the search words. The study designs 54 
included were randomized or quasi-randomised controlled trials in the English language and there was 55 
no date restriction. Details of the systematic review protocol and search strategy are available in 56 
supplementary material (Tables a and b).  57 
 58 
Inclusion criteria 59 
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A study was eligible if it was a randomized or quasi-randomized controlled trial and participants were 60 
both of very low birth weight (<1500 grams) and fed exclusively or predominantly with EBM (either 61 
mother`s own milk or pasteurized donor human milk). We included only studies designed to evaluate 62 
early fortification (i.e. added at small enteral volume) versus delayed fortification (i.e. added at larger 63 
enteral volume). At least one of our primary outcomes had to be measured. A study was excluded if it 64 
did not meet these criteria or included babies with congenital anomalies. 65 
Outcomes  66 
The primary outcomes of this systematic review were short-term growth parameters (length, head 67 
growth and weight gain), Feeding intolerance (defined as clinical signs only and/or cessation of feeding), 68 
length of hospital stay (number of days that the baby remained in the neonatal unit) and PMA (i.e. 69 
gestational age plus chronological age) at discharge. Secondary outcomes were NEC and sepsis. 70 
Study selection and data extraction  71 
To avoid bias in the study selection, the first reviewer, WA, screened all titles. Three other reviewers, CE, 72 
ALG and JS, screened all the titles again independently to make the final decision and ensure no study 73 
was missed. After that, WA reviewed the abstracts of all potentially relevant studies and obtained their 74 
full text. WA assessed full texts against the predetermined inclusion and exclusion criteria with the help 75 
of an inclusion checklist form (Appendix, form 1). Excluded studies were double-checked by two 76 
reviewers, CE and ALG. WA extracted the data from the studies meeting the inclusion criteria using data 77 
extraction sheet (Appendix, form 2). The following data items were extracted: publication year, authors, 78 
study settings, country where study carried out, design, participants, nutrition intervention and 79 
outcomes of interest. Data were entered onto Microsoft Excel.  80 
Individual study risk of bias and quality assessment 81 
Three reviewers (WA, CE and AG) independently assessed the risk of bias and the overall quality of each 82 
study. Criteria suggested by the Cochrane Collaboration tool were applied. Judgment for potential bias 83 
in each study methodology was classified as being of low, high or unclear risk according to the following 84 
domains: random sequence generation, allocation concealment, blinding of participants and personnel, 85 
blinding of outcome assessment, incomplete outcome data and selective reporting (16). The quality of 86 
each individual study was assessed using a scoring tool that we developed. The criteria for quality 87 
assessment considered the following aspects: the number of centres involved in the study, sample size, 88 
description of the intervention, reporting outcomes definition and method of measurement, study 89 
groups’ homogeneity and consideration of confounding factors. Details of our systematic review 90 
protocol are available in the supplementary material. 91 
4. Results 92 
Searches 93 
Database searches returned 5442 articles, and an additional 25 articles were found through a manual 94 
search. After duplicates were removed, the titles of 1972 articles were screened for relevance, resulting 95 
in the exclusion of 1805 articles. The remaining 167 articles were then assessed by reference to their full 96 
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texts. After applying our eligibility criteria, 165 records were excluded, and two studies (17, 18) were 97 
included in this review (Figure 1). 98 
Description of the included studies (n=2) 99 
The studies’ characteristics are summarized in Table 1. The initial sample size was 100 in the trial by 100 
Shah et al. (17) and 80 in the trial by Alizadeh et al. (18). The studies occurred in two distinct 101 
geographical regions. One study was carried out in the USA between 2013 and 2015 (17), while the 102 
other was done in Iran between 2012 and 2013 (18). Both studies were published in 2016. One study 103 
was conducted in two NICUs (17) and the other in one NICU (18). Both studies included only preterm 104 
infants. In one study, the eligibility criteria included infants below 1500 g at birth (17), while the other 105 
study allowed low birth weights (<2000 g) to be included; this study was included in the review because 106 
the average birth weight of the participants was 1295 g. Both studies excluded infants with congenital 107 
anomalies. Infants in the study by Alizadeh who had to be fed formula because of insufficient MOM 108 
supply were excluded. The average gestational age in the two studies was 29.1 weeks.  109 
There was inconsistency in the definitions of early fortification (EF) and later or delayed fortification (DF) 110 
between the two studies. In the study by Shah, EF started at 20 ml/kg/d, and DF started at 100 ml/kg/d. 111 
This study did not report the postnatal age at which fortification was initiated. In the study by Alizadeh, 112 
EF was reported as ‘first feeding’ and DF was commenced at 75 ml/kg/d. First feeding was described as 113 
starting on the ‘first day’, as trophic feeding at a rate specific to birth weight and maturity level. They 114 
reported that the mean postnatal age at introduction of fortification in the EF group was 3.7 days.   115 
Infants were fed exclusively with human milk in both studies. In the study by Shah, infants were fed both 116 
MOM and DHM. Infants in the DF group received a higher proportion of DHM than those in the EF group 117 
(67% vs. 54%) but it was not reported if this was statistically significant. In the study by Alizadeh, infants 118 
were fed only MOM. In both studies, the fortifier used was of bovine origin and the method used for 119 
fortification was the addition of a standard amount for all babies rather than an individualized approach. 120 
Both trials aimed to increase EBM caloric density to 24 kcal/oz. Fortification was continued until the 121 
weight reached 3000 g in the study by Alizadeh, but the study by Shah did not report a criterion for 122 
discontinuing fortification.  123 
The definition of NEC, feeding intolerance and sepsis outcomes varied between the two studies. In 124 
Shah’s study, feeding intolerance was defined as symptoms or signs   leading to feeding cessation, 125 
whereas in the study by Alizadeh it was defined as signs of feeding intolerance only. NEC was defined in 126 
Shah’s study using Bell’s criteria (Stage II or more), but the other study used a list of clinical, laboratory 127 
and radiological diagnostic criteria. In the study by Shah, sepsis was defined by clinical signs of sepsis 128 
proven by blood culture, whereas the other study defined it by clinical signs only. Definitions for all 129 
reported outcomes are listed in the supplementary file (Table E). 130 
Individual studies’ risks of bias and quality assessments 131 
There was a low risk of selection bias in the study by Shah. In Alizadeh’s study, the risk of selection bias 132 
was unclear, as no details were provided on the tool used to perform block randomization, and the 133 
allocation was concealed. There was a high risk of performance bias in the trial by Shah, as the blinding 134 
of infants’ caregivers and the research investigator was not possible due to the fortification of EBM 135 
occurring at the bedside. In the trial by Alizadeh, the risk of performance bias was unclear, as no details 136 
were provided. The risk of detection bias was unclear in both studies. There was a low risk of attrition 137 
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bias in both studies, as most of the participants remained in the study until the intervention ended (90 138 
% in Alizadeh’s study and 99 % in Shah’s study). No selective reporting was observed in either trial (Table 139 
3). Shah’s study was evaluated to be of high quality, while the other study was evaluated to be of 140 
moderate quality (Table 4). 141 
Effect of EF versus DF on outcomes 142 
Most of the primary and secondary outcomes were measured in both studies with the exception of 143 
length of hospital stay, which was reported by only one study (Shah’s study). Neither study reported 144 
PMA at discharge. The primary outcome in the study by Shah was days to reach full feeding, while in-145 
hospital growth was the primary outcome in Alizadeh’s study. Due to the small number of included 146 
studies, meta-analysis was not performed. Data on all primary outcomes except length of stay were 147 
available for 171 infants in the two trials. Length-of-stay data were available for 99 infants in the trial by 148 
Shah. Neither study reported differences between groups including NEC or sepsis (Table 2). 149 
5. Discussion/Conclusion 150 
The main finding of this systematic review is that there is insufficient evidence to evaluate the effects of 151 
EF against DF of human milk in VLBW infants. Despite screening a large number of international studies 152 
using a robust search strategy, we found little evidence on the benefits of EF versus DF. The number of 153 
studies was small, and the definitions of EF and DF varied. In one of the included trails, by Shah et al., 154 
the primary outcome was days to achieve full feeding volume. They showed that the median days to 155 
achieve full feeding and the number of events of feeding intolerance were similar in the EF and DF 156 
groups. Some published studies that did not meet our inclusion criteria showed some benefits of EF. 157 
One observational study compared EF (80 ml/kg/day) with DF (160 ml/kg/d) in late preterm infants and 158 
found that infants in the EF group regained their birth weight faster and had fewer events of feeding 159 
intolerance (21). A clinical trial by Sullivan et al. (which was not designed to compare EF with DF) 160 
showed that fortification with human-milk-based fortifier was tolerated at 40 ml/kg/day (22). An 161 
observational study by Tillman et al. showed that EF (from the first feeding) improved bone 162 
mineralisation (lower alkaline phosphate) and did not have higher events of feeding intolerance (23). 163 
Nevertheless, proper randomised clinical trials designed to evaluate the effectiveness and safety of EF in 164 
high-risk infants are needed to inform feeding practice.   165 
Although optimising nutrition for preterm infants is advantageous in terms of improved short-term 166 
growth, there remains a lack of evidence on the longer-term benefits of fortification of EBM. A recently 167 
published Cochrane meta-analysis comparing the growth and developmental outcomes of using fortified 168 
EBM against unfortified EBM found insufficient data from which to draw any meaningful conclusions 169 
(19). Despite a rigorous search methodology, the authors concluded that there is limited evidence for 170 
evaluating the benefits of multi-nutrient fortification of EBM against unfortified EBM. 171 
In summary, current evidence does not provide guidance on the optimal time to start fortification. 172 
Further and larger randomised clinical trials comparing the effect of EF versus DF are needed. Future 173 
studies should measure core outcomes that are important for both parents and health professionals to 174 
allow results to be compared and combined(24).   175 
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Table 1. Characteristics of the included studies 
 Shah et al Alizadeh et al 
Methods    
Settings /Study period Two NICUs in USA/ /2013-2015 One NICU in Iran/ 2012-2013 
Objective  To compare human milk fortification at 
two different feeding volumes on time 
to reach full feeding and feeding 
intolerance  
Compare early versus delayed 
fortification on growth, feeding 
intolerance, sepsis and NEC.  
Participants   
Inclusion criteria  Preterm, Birth weight < 1500 g Preterm, Birth weight <2000 g 
Exclusion criteria  Died or expected to die before 72 
hours of life, major congenital or 
chromosomal abnormality, no MOM 
or refused DHM 
Major congenital anomalies, 
transferred to another hospital, did 
not attend the neonatal clinic follow-
up, had to be fed with formula due 
to insufficient MOM.   
N randomized /analyzed  100/99 80/72 
Gestational age  Median (25th ,75th centile)=27.8 (26, 
30)1 
Mean ± standard deviation =30.4 ± 
1.91 
Birth weight   Median (25th ,75th centile)= 990 
(810,1225)1 
Mean ± standard deviation =1295 ± 
3791 
Nutrition management    
Day EN started  3 (2.5 ,4) One  
EN  advancement rate 10-20 ml/kg/d 10-20 ml/kg/d 
Milk of feeding  MOM or DHM  MOM 
Intervention description    
Definition of EF   20 ml/kg/d First feeding 
Definition of DF   100 ml/kg/d 75 ml/kg/d 
Age at fortification  No data  EF: 3.7 ± 2.76 
DF: 9.48 ± 5.31 
Fortifier name  Enfamil HMF liquid Aptamil FMS 
Fortifier type  Bovine origin 
Acidified liquid HMF 
Bovine origin 
Powder 
Fortifier dose  Five ml added to 25 ml of EBM 4.4 g added to 100 ml of EBM 
Duration of fortification  No data on criteria to stop fortification Until weight reaches 3 kg.  
Fortified EBM energy 
density  
24 kcal/oz. 24 kcal/oz.  
Fortification method Standard  Standard  
1 Average value is calculated for the two study groups 
 
 
Table 2. Effect of EF versus DF on outcomes 
Outcome  Study  Unit  Early fortification Delayed fortification  P value 
Weight gain       
 Shah, g/kg/d ,4 wk of life median (IQR) 8.7 (6.4,12.2) 7.7 (5.1,10.6) 0.08 
 Shah, g/kg/d ,36 wk PMA median (IQR) 18.3 (14.9,20.7)  16.7 (13.9,22)  0.3 
 Alizadeh z score -1.24 (-3.74 to 0.84) -1.23 (-3.92 to 1.16) 0.864 
Head growth       
 Shah ,4 wk of life  mean (SD) -0.97 (0.91) -0.95 (1.0) 0.90 
 Shah, 36 wk PMA mean (SD) -0.71 (1.08) -0.65 (1.07) 0.80 
 Alizadeh  z score -5.15 (-0.95 to 1.66) -0.43 (-2.77 to 1.10) 0.787 
Length gain      
 Shah, 4 wk of life  mean (SD) -1.0 (0.57) 0.97 (0.69) 0.81 
 Shah, 36 wk PMA mean (SD) -1.58(0.93) 1.59 (0.89) 0.93 
 Alizadeh z score -0.14 (-3.74 to 2.26) -0.44 (-4.11 to 1.82) 0.348 
Feeding intolerance      
 Shah  N (%) 15 (31) 15 (30) 1 
 Alizadeh  N (%) 5 (14) 3 (9) 0.771 
Length of hospital 
stay (d) 
     
 Shah median (IQR) 68 (41,101)  63 (50,83)  0.49 
Necrotizing 
enterocolitis  
     
 Shah  N (%) 2 (4) 2 (4) 1 
 Alizadeh  N (%) 2 (6) 0 0.223 
Sepsis       
 Shah  N (%) 3 (6) 6(12) 0.49 
 Alizadeh  N (%) 2 (6) 1(3) 0.572 
IQR: interquartile range, SD: standard deviation. wk : weeks, The number of participants analysed for all outcomes in study by shah 
(EF=49, DF=50) and in study by Alizadeh (EF= 36, DF=36) 
 
Table 3. Risk of bias assessment 
 Shah et al  Alizadeh et al 
Domain Review 
authors’ 
judgement  
support for judgement Review 
authors’ 
judgement and  
support for judgement 
Selection bias     
Random sequence 
generation 
 
Low risk  Use of blocked stratified randomisation 
approach by computerized software.   
Unclear risk Block randomisation method, no 
details how.    
Allocation concealment Low risk 
 
The research coordinator and principal 
investigator performed the enrolment and 
assignment of infants after randomization  
Unclear risk Double blinded, no details how  
Performance bias     
Blinding of participants and 
personnel (all outcomes) 
 
High risk Infants’ caregiver and research investigators 
were not blinded. Fortification (intervention) 
occurred at bedside, blinding was not possible. 
Unclear risk It was not reported if the 
caregiver and researcher were 
blinded.  
Detection bias     
Blinding of outcome 
assessment 
Unclear risk  Was not clearly reported if the outcomes 
measurers were blinded  
Unclear risk It is unclear if the outcome 
measurer was blinded at the time 
of outcome measurement   
Attrition bias     
Incomplete outcome data Low risk  99 % of the participant were analysed  Low risk  90 % of the participant were 
analysed 
Reporting bias     
Selective reporting 
 
Low risk  Outcomes were reported  Low risk  Outcomes were reported  
 
Table 4. Quality assessment of the included studies 
 Score 
Shah et al 
Rational  Score  
Alizadeh et al 
Rational 
Multicentre  1 Two centers 0 One centre  
Sample Size 1 99 infants included 1 72 infants included  
Description of Intervention 2 EF and DF was clearly defined 
as ml/kg/d 
1 EF was defined as ‘first feeding’, specific 
volume was not reported.  
Baseline characteristics comparable   1 EF and DF groups had similar 
demographic  
1 EF and DF groups had similar 
demographic 
Outcomes defined 1 Yes  1 Yes  
Outcomes measurement described  1 Yes  0 Yes  
Confounding factors   1 RCT but 13 % difference in 
DHM intake between groups. 
Not reported if statistically 
significant.    
1 RCT   
Score (Quality level)  8 (High)   5 (moderate) 
 
 
